ERBB4 and breast carcinoma: Several basal miRNAs (miR-125b, miR-142, miR-152, miR-146b, miR-222, and miR-212) have also been predicted to target luminal factors that have been previously identified in breast cancer, including ERBB2, ERBB3, ERBB4, and FOXA1 [26-28].